An evaluation of the biological response to Fraxiparine, (a low molecular weight heparin) in the healthy individual.
about
Enoxaparin-Induced Liver Injury: Case Report and Review of the Literature and FDA Adverse Event Reporting System (FAERS)Low molecular weight heparins: an emerging new class of glycosaminoglycan antithrombotics.The effects of intraperitoneal piroxicam and low molecular weight heparin in prevention of adhesion reformation in rat uterine horn.Anti-Xa Levels 4 h After Subcutaneous Administration of 5,700 IU Nadroparin Strongly Correlate with Lean Body Weight in Morbidly Obese Patients.
P2860
An evaluation of the biological response to Fraxiparine, (a low molecular weight heparin) in the healthy individual.
description
1990 nî lūn-bûn
@nan
1990 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
An evaluation of the biologica ...... in) in the healthy individual.
@ast
An evaluation of the biologica ...... in) in the healthy individual.
@en
type
label
An evaluation of the biologica ...... in) in the healthy individual.
@ast
An evaluation of the biologica ...... in) in the healthy individual.
@en
prefLabel
An evaluation of the biologica ...... in) in the healthy individual.
@ast
An evaluation of the biologica ...... in) in the healthy individual.
@en
P2093
P2860
P1476
An evaluation of the biologica ...... in) in the healthy individual.
@en
P2093
P2860
P304
P356
10.1002/J.1552-4604.1990.TB03633.X
P577
1990-08-01T00:00:00Z